Oxidative Stress in SLE T Cells, Is NRF2 Really the Target to Treat?
- PMID: 33968025
- PMCID: PMC8102865
- DOI: 10.3389/fimmu.2021.633845
Oxidative Stress in SLE T Cells, Is NRF2 Really the Target to Treat?
Abstract
Oxidative stress is a major component of cellular damage in T cells from patients with systemic lupus erythematosus (SLE) resulting amongst others in the generation of pathogenic Th17 cells. The NRF2/Keap1 pathway is the most important antioxidant system protecting cells from damage due to oxidative stress. Activation of NRF2 therefore seems to represent a putative therapeutic target in SLE, which is nevertheless challenged by several findings suggesting tissue and cell specific differences in the effect of NRF2 expression. This review focusses on the current understanding of oxidative stress in SLE T cells and its pathophysiologic and therapeutic implications.
Keywords: Foxp3; Keap 1; ROS; Tregs; lupus; mTOR.
Copyright © 2021 Ohl and Tenbrock.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
Similar articles
-
Altered redox regulation by Nrf2-Keap1 system in dendritic cells of systemic lupus erythematosus patients.Lupus. 2020 Oct;29(12):1544-1555. doi: 10.1177/0961203320950022. Epub 2020 Aug 18. Lupus. 2020. PMID: 32811277
-
Amelioration of Oxidative Stress in Caco-2 Cells Treated with Pro-inflammatory Proteins by Chlorogenic Acid Isomers via Activation of the Nrf2-Keap1-ARE-Signaling Pathway.J Agric Food Chem. 2018 Oct 24;66(42):11008-11017. doi: 10.1021/acs.jafc.8b03983. Epub 2018 Oct 15. J Agric Food Chem. 2018. PMID: 30259744
-
4-Octyl Itaconate Activates Nrf2 Signaling to Inhibit Pro-Inflammatory Cytokine Production in Peripheral Blood Mononuclear Cells of Systemic Lupus Erythematosus Patients.Cell Physiol Biochem. 2018;51(2):979-990. doi: 10.1159/000495400. Epub 2018 Nov 22. Cell Physiol Biochem. 2018. PMID: 30466076
-
Targeting the KEAP1-NRF2 System to Prevent Kidney Disease Progression.Am J Nephrol. 2017;45(6):473-483. doi: 10.1159/000475890. Epub 2017 May 13. Am J Nephrol. 2017. PMID: 28502971 Review.
-
Toxico-pharmacological perspective of the Nrf2-Keap1 defense system against oxidative stress in kidney diseases.Biochem Pharmacol. 2013 Apr 1;85(7):865-72. doi: 10.1016/j.bcp.2013.01.006. Epub 2013 Jan 17. Biochem Pharmacol. 2013. PMID: 23333765 Review.
Cited by
-
The Pathophysiology of The Antiphospholipid Syndrome: A Perspective From The Blood Coagulation System.Clin Appl Thromb Hemost. 2022 Jan-Dec;28:10760296221088576. doi: 10.1177/10760296221088576. Clin Appl Thromb Hemost. 2022. PMID: 35317658 Free PMC article. Review.
-
T Cell Nrf2/Keap1 Gene Editing Using CRISPR/Cas9 and Experimental Kidney Ischemia-Reperfusion Injury.Antioxid Redox Signal. 2023 May;38(13-15):959-973. doi: 10.1089/ars.2022.0058. Epub 2023 Mar 16. Antioxid Redox Signal. 2023. PMID: 36734409 Free PMC article.
-
CD8+ T regulatory cells in lupus.Rheumatol Immunol Res. 2021 Dec 15;2(3):147-156. doi: 10.2478/rir-2021-0021. eCollection 2021 Sep 1. Rheumatol Immunol Res. 2021. PMID: 35880241 Free PMC article. Review.
-
4-Octyl Itaconate Inhibits Proinflammatory Cytokine Production in Behcet's Uveitis and Experimental Autoimmune Uveitis.Inflammation. 2024 Jun;47(3):909-920. doi: 10.1007/s10753-023-01950-y. Epub 2024 Jan 6. Inflammation. 2024. PMID: 38183531
-
Redox Homeostasis Involvement in the Pharmacological Effects of Metformin in Systemic Lupus Erythematosus.Antioxid Redox Signal. 2022 Mar;36(7-9):462-479. doi: 10.1089/ars.2021.0070. Epub 2022 Jan 4. Antioxid Redox Signal. 2022. PMID: 34619975 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous